Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma
Edward Libby, MD, and Josh Epworth, ARNP, interpreted data on current and novel treatments, discussed how to select initial therapy based on patient risk and in alignment with guidelines and best practices, and evaluated the use of minimal residual disease testing in patients with multiple myeloma.
Gespeichert in:
| Veröffentlicht in: | Journal of the advanced practitioner in oncology 2020-04, Vol.11 (3), p.301-305 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | Edward Libby, MD, and Josh Epworth, ARNP, interpreted data on current and novel treatments, discussed how to select initial therapy based on patient risk and in alignment with guidelines and best practices, and evaluated the use of minimal residual disease testing in patients with multiple myeloma. |
|---|---|
| ISSN: | 2150-0878 2150-0886 |
| DOI: | 10.6004/jadpro.2020.11.3.17 |